Excited to present on our game-changing nerve imaging technology at the 2024 World Congress of Endourology and Uro-Technology in Seoul, Korea. Real-time visualization of pelvic nerves during urology surgery could eliminate surgical nerve damage and the associated debilitating side effects for millions of patients. #WCET24
Trace Biosciences
生物技术研究
Portland,Oregon 889 位关注者
Trace Biosciences is working to eliminate surgical nerve damage using an imaging agent for enhance nerve identification
关于我们
Trace Biosciences is creating imaging agents for surgery. Our mission is to revolutionize surgery by highlighting detailed anatomy in real-time. Our first product is a nerve targeting imaging agent that will prevent surgical nerve damage. Nerve injury is a feared surgical complication affecting 25 million patients annually and incurring undue pain, loss of function, and high cost for follow on treatment and pain management. Currently, surgeons are entirely unassisted in nerve identification and preservation, relying solely on naked eye visualization or anatomical knowledge. If we can successfully develop this, our imaging agents will be used in almost all operating theaters, enable true precision surgery, and vastly improve patient outcomes. We are well funded through non-dilutive grants (SBIR, STTR + regional government) as well as venture capital investments. Founded in 2019 we are now developing our first products that will enter clinical trials in 2023.
- 网站
-
trace-bio.com
Trace Biosciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Portland,Oregon
- 类型
- 私人持股
- 创立
- 2019
地点
-
主要
4640 S Macadam Ave
US,Oregon,Portland,97201
Trace Biosciences员工
动态
-
Congratulations to Trace Biosciences and Connor Barth for winning the judges award at the Life Science Innovation Northwest Fast Pitch event yesterday! Trace Biosciences is creating targeted imaging agents that allow surgeons to visualize and avoid nerves in real time during surgery. Learn more about Trace Biosciences: https://www.trace-bio.com/